JP2017530185A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530185A5
JP2017530185A5 JP2017518989A JP2017518989A JP2017530185A5 JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5 JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5
Authority
JP
Japan
Prior art keywords
methyl
dichlorophenyl
dihydroisoquinolin
ethanone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017530185A (ja
JP6622299B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073053 external-priority patent/WO2016055479A1/en
Publication of JP2017530185A publication Critical patent/JP2017530185A/ja
Publication of JP2017530185A5 publication Critical patent/JP2017530185A5/ja
Application granted granted Critical
Publication of JP6622299B2 publication Critical patent/JP6622299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518989A 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体 Active JP6622299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188174 2014-10-08
EP14188174.8 2014-10-08
PCT/EP2015/073053 WO2016055479A1 (en) 2014-10-08 2015-10-06 Tetrahydroisoquinoline derivatives

Publications (3)

Publication Number Publication Date
JP2017530185A JP2017530185A (ja) 2017-10-12
JP2017530185A5 true JP2017530185A5 (enExample) 2019-10-03
JP6622299B2 JP6622299B2 (ja) 2019-12-18

Family

ID=51790569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518989A Active JP6622299B2 (ja) 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体

Country Status (18)

Country Link
US (1) US10105359B2 (enExample)
EP (1) EP3204359B1 (enExample)
JP (1) JP6622299B2 (enExample)
CN (1) CN107001278B (enExample)
BR (1) BR112017007123B1 (enExample)
CA (1) CA2963951C (enExample)
CY (1) CY1123417T1 (enExample)
DK (1) DK3204359T3 (enExample)
EA (1) EA035544B1 (enExample)
ES (1) ES2821821T3 (enExample)
HR (1) HRP20201469T1 (enExample)
HU (1) HUE050664T2 (enExample)
LT (1) LT3204359T (enExample)
PL (1) PL3204359T3 (enExample)
PT (1) PT3204359T (enExample)
RS (1) RS60933B1 (enExample)
SI (1) SI3204359T1 (enExample)
WO (1) WO2016055479A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3012560A1 (en) * 2016-02-25 2017-08-31 Asceneuron S.A. Glycosidase inhibitors
JP6908623B2 (ja) * 2016-04-13 2021-07-28 ユーシービー バイオファルマ エスアールエル テトラヒドロイソキノリン誘導体
CN107698433A (zh) * 2017-09-12 2018-02-16 潍坊滨海石油化工有限公司 苯乙酸的制备方法
EA202091323A1 (ru) 2017-12-01 2020-10-09 Юсб Байофарма Срл Визуализирующие средства
TWI725408B (zh) * 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
CN114008032B (zh) * 2019-07-01 2023-11-10 Ucb生物制药有限责任公司 作为d1正变构调节剂的取代的四氢异喹啉衍生物
AU2020299953B2 (en) * 2019-07-01 2025-06-05 UCB Biopharma SRL A substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator
CN115916338A (zh) * 2020-04-24 2023-04-04 加利福尼亚大学董事会 Nurr1受体调节剂及其用途
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
DK4200280T3 (da) * 2020-10-07 2024-03-04 Lilly Co Eli Phenyl-3,4-dihydroisoquinolin-2(1H)-yl-ethan-on-derivater som positive allosteriske modulatorer af dopamin-D1-receptorer
WO2022117678A1 (en) 2020-12-03 2022-06-09 UCB Biopharma SRL Octahydroisoquinolinyl derivatives
US20240083875A1 (en) 2020-12-18 2024-03-14 UCB Biopharma SRL Dihydroisoquinolinyl derivatives
CN116601161A (zh) * 2020-12-18 2023-08-15 Ucb生物制药有限责任公司 2-(3,5-二氯-1-甲基-吲唑-4-基)-1-[(1s,3r)-3-(羟基甲基)-5-(1-羟基-1-甲基-乙基)-1-甲基-3,4-二氢-1h-异喹啉-2-基]乙酮的前药
US20240000769A1 (en) * 2020-12-18 2024-01-04 UCB Biopharma SRL Amorphous solid dispersions
PL4263517T3 (pl) * 2020-12-18 2025-03-31 UCB Biopharma SRL Podstawiona pochodna tetrahydroizochinoliny jako pozytywny modulator allosteryczny d1
AU2022234744B2 (en) 2021-03-08 2025-06-26 Eli Lilly And Company Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis
CN117337173A (zh) 2021-03-09 2024-01-02 伊莱利利公司 美维达林和其他d1正向别构调节剂用于减缓帕金森氏病进展的用途
CN114671810B (zh) * 2022-03-21 2024-03-22 济南鸿湾生物技术有限公司 一种咪唑苯脲的制备方法
CN115611768B (zh) * 2022-11-14 2024-03-05 郑州大学 一种3,4-二氯苯腈的合成方法
CN118724764B (zh) * 2024-06-07 2025-11-18 绍兴文理学院 一种芳基伯磺酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
MXPA04005988A (es) * 2001-12-19 2004-09-27 Lundbeck & Co As H 3,4-dihidro-1h-isoquinolin-2-il-derivados.
JP4685861B2 (ja) * 2004-04-29 2011-05-18 アベンティス・ファーマスーティカルズ・インコーポレイテツド ドーパミンアゴニストとしての3−ピペリジニルイソクロマン−5−オール
MX2009009415A (es) * 2007-03-01 2009-09-11 Janssen Pharmaceutica Nv Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.

Similar Documents

Publication Publication Date Title
JP2017530185A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (enExample)
ES2629414T3 (es) Derivados de tiazol
JP2021500345A5 (enExample)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
JP2020506946A5 (enExample)
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2014506599A5 (enExample)
JP2010510319A5 (enExample)
JP2016523911A5 (enExample)
JP2017503837A5 (enExample)
JP2016513660A5 (enExample)
JP2017511794A5 (enExample)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2014526549A5 (enExample)
JP2019513776A5 (enExample)
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2018511587A5 (enExample)
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2015523390A (ja) 置換型ピラゾロン化合物及び使用方法
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1